HANMI PHARM. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,00,000 KRW | +0.67% |
|
-7.55% | -14.89% |
| 16/05 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 08/05 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 276.95Cr | ||||||
| 4.29TCr | ||||||
| 2.14TCr | ||||||
| 1.51TCr | ||||||
| 1.44TCr | ||||||
| 1.3TCr |
